Develops and manufactures drugs related to immunology, neurobiology and oncology

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Samaritan Pharmaceuticals, Inc. operates as an entrepreneurial biopharmaceutical company. It focuses on commercializing innovative therapeutic products to relieve patients suffering from Alzheimer's disease, cancer, cardiovascular disease, HIV, and Hepatitis C as well as commercializing its acquired marketing and sales rights, to sell marketed revenue-generating products, in Greece, and/or various Eastern European countries. The company was founded by Welter Holden on September 5, 1994 and is headquartered in Las Vegas, NV.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) for the treatment of a wide range of diseases with an initial focus on cancer. Members of our founding and scientific teams previously developed the first FDA approved modulators of Cereblon, the most widely validated E3 ligase involved in protein degradation, and have applied their expertise in Cereblon binding to build our proprietary PRODEGY platform. Our platform leverages an extensive patent protected and rationally designed library of Cereblon binders that we believe provides us with a differentiated starting point for drug design of molecular glues, bifunctional degraders and hybrid degraders.

Institut du Cerveau et de la Moelle ��pini��re is a French private company located in Paris. The firm engages in spinal cord and brain research and educational services. It was founded by Maurice L��vy and Serge Weinberg.

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Liaoning Guangtai Pharmaceutical Co., Ltd., established on 2001-06-11, The business scope includes Chinese herbal medicines,Chinese Herbal Medicine,Buying and selling native products;Chinese herbal medicine seeds,Wholesale Seedlings,retail.food production,processing.food,Health products,Cosmetics Wholesale,retail;Medicinal Plant Planting,breeding;medicinal animal farming,Harvesting wild medicinal plants;Primary processing of medicinal plants;Rana oil primary processing;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Vaccinex has developed an antibody discovery platform that enables efficient mammalian cell-based expression for expression of large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface envelope of a mammalian virus and the cell surface membrane of the infected cell. This allows them to combine the advantages of virus panning and cell sorting into one seamless selection process. This technology enables the rapid selection of 1010 antibody combinations and thus selection of high affinity leads with varied frameworks that recognize multiple epitopes. It is based in Rochester, New York.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Dongguan Kaifa Biopharmaceutical Co., Ltd., established on 2001-08-17, Business scope includes biomedical product technology,traditional Chinese medicine,Research and development of biochemical drugs and health food,Research and Development of Medical Devices,Transfer of medical technology and products,consult,Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)